Can You Change Your Biological Age? What the Research Actually Shows

Can You Change Your Biological Age? What the Research Actually Shows

It's the question behind every report review call: Is this actionable? Seeing a biological age higher than your chronological age, or a DunedinPACE above 1.0, only matters if there's something you can do about it.

The answer is yes — and the evidence base is growing fast.

Methylation is dynamic

The foundational point: DNA methylation is not fixed. It changes throughout life in response to what the body experiences — diet, exercise, sleep, stress, environmental exposures, medications. This is one of the core insights of epigenetics, and it's what makes TruAge and TruHealth measurements meaningful as clinical targets rather than just informative readouts.

Methylation patterns that have shifted in the wrong direction can, in many cases, shift back. This isn't a speculative claim — it's demonstrated in peer-reviewed literature across multiple interventions, biomarkers, and populations.

The evidence for biological age reversal

Some of the most compelling evidence comes from studies that didn't set out to study epigenetic aging at all. Researchers following patients through lifestyle interventions — diet changes, exercise programs, stress reduction protocols — found that methylation-based biological age clocks moved in the expected direction. The effect wasn't subtle.

An exploratory study by Fahy et al. (2019, Aging Cell) used a combination of growth hormone, DHEA, and metformin in a small cohort (9 men) and measured effects across four epigenetic clocks. [1] The within-group change was approximately 1.5 years of epigenetic age reduction after 12 months; compared against an untreated reference group, the effect was closer to 2.5 years. The study was small, but it demonstrated something important: biological age clocks can be reversed, not just slowed.

More recently, a placebo-controlled trial of semaglutide (n=84) found measurable epigenetic changes, including a 9% slowing of DunedinPACE and an average 3.1-year biological age reversal across multiple clocks. [2] TruDiagnostic scientists were co-authors on this research. One caveat worth noting: the trial population was adults with HIV-associated lipohypertrophy, not a general metabolic population — promising evidence, but not yet confirmation that the effect holds broadly across all patients on GLP-1 therapy. For providers already prescribing these medications, the epigenetic data adds a new dimension to the story of what these drugs are actually doing, with more research underway to confirm how broadly it applies.

What interventions have the strongest evidence

Diet

The Mediterranean dietary pattern has one of the more robust epigenetic evidence bases for diet, though strength of evidence varies by clock. The NU-AGE trial found that a 1-year Mediterranean-style diet produced measurable epigenetic rejuvenation on the Horvath clock, most pronounced in participants who started epigenetically older. [3] Separate research has reported that a polyphenol-rich Green-Mediterranean variant could improve epigenetic age. [4] The likely mechanism involves reduced chronic inflammation, improved micronutrient status (particularly B vitamins, omega-3s, and polyphenols), and favorable effects on the gut microbiome and methylation pathways.

Caloric restriction and time-restricted eating have also shown epigenetic aging benefits in both animal models and early human studies. The effect appears to be at least partially independent of weight loss.

Exercise

Both aerobic exercise and resistance training demonstrate epigenetic aging benefits. Aerobic exercise at moderate-to-vigorous intensity shows consistent associations with slower DunedinPACE in observational studies and improvements in biological age in some interventional studies. Resistance training is associated with better telomere length preservation and reduced cellular aging markers. The combination appears more effective than either alone.

Sleep

Poor sleep quality is consistently associated with faster DunedinPACE in observational population data. [5] The evidence here is mostly associational rather than interventional — there isn't yet a large trial directly showing that improving sleep slows DunedinPACE — but early findings suggest sleep-related methylation changes are at least partly reversible with improved sleep. Sleep is a promising modifiable factor for DunedinPACE, though the direct interventional evidence is still developing.

Stress reduction

Chronic psychological stress is a consistent accelerator of biological aging in the epigenetic literature. Mindfulness-based stress reduction and other structured stress interventions have shown measurable effects on epigenetic markers. The mechanism involves multiple pathways: HPA axis regulation, inflammatory pathway activity, and direct effects on methylation-cycle efficiency.

Supplements

The evidence for supplements is more mixed than for lifestyle factors, but several stand out:

• B vitamins (folate, B12, B6): Directly involved in the one-carbon metabolism pathway that drives methylation. Functional deficiency — particularly in patients with MTHFR or related variants — can impair methylation capacity broadly. Repleting with methylated forms can have measurable effects on methylation-dependent processes.
• Omega-3 fatty acids: The DO-HEALTH trial (777 older adults, 3-year RCT) found that 1g/day of omega-3 alone slowed DNAm PhenoAge, GrimAge2, and DunedinPACE, with effects growing when combined with vitamin D and exercise. [6] This is one of the better-supported supplement claims here — real RCT evidence, not just observational association.
• NAD+ precursors (NMN, NR): Growing interest in clinical application; early data suggests NAD+ repletion may support DNA repair and methylation efficiency, though robust human trial data remains limited.
• CoQ10: Supports mitochondrial function, which is upstream of methylation pathway efficiency. Particularly relevant for patients with mitochondrial markers flagged on TruHealth.

Medications

• GLP-1 receptor agonists (semaglutide, tirzepatide): A placebo-controlled trial co-authored by TruDiagnostic scientists showed meaningful epigenetic aging benefits — slowing DunedinPACE and improving metabolic and inflammatory EBPs. [2] This is one of the most exciting intersections between conventional pharmacology and epigenetic aging research currently, though the trial was conducted in a specific population (HIV-associated lipohypertrophy) and broader confirmation is still underway.
• Metformin: Long used for type 2 diabetes and increasingly studied as a longevity intervention. It was part of the pharmacological protocol in the Fahy et al. epigenetic age reversal study. Evidence is strongest in diabetic populations — studies show slower epigenetic aging on the Horvath and Hannum clocks in patients with diabetes. [7] Results are more mixed outside that population: a 6-month RCT in postmenopausal breast cancer survivors found no significant epigenetic age effect, so the benefit may be population-dependent rather than universal.
• Rapamycin: Early human research (following extensive animal data) has so far reported null results for mTOR inhibition when it comes to epigenetic aging.

How long does it take?

This is one of the most common questions providers ask — and the honest answer is that it depends on the intervention and the marker.

DunedinPACE is the most responsive clock. Because it reflects current pace rather than accumulated state, meaningful interventions can produce measurable changes within three months. It's the best indicator to follow for early confirmation that an intervention is working.

Biological age (OMICm Age and Symphony Age) can take longer. It's a reflection of accumulated history, so it responds more slowly. Expect at least six months of consistent intervention before meaningful biological age movement — and some of the benefit may show first in DunedinPACE before it appears in overall biological age.

EBPs vary by marker. Inflammatory and metabolic markers can shift relatively quickly — sometimes within three to four months of relevant dietary or supplementation changes. Markers reflecting more structural biological processes (mitochondrial function, cellular aging) tend to take longer.

A note on realistic expectations

Improving epigenetic age is possible. Slowing the pace of aging is achievable. But this is a long game — and the patients who benefit most are those who understand that TruDiagnostic testing is a longitudinal tracking tool, not a one-time health snapshot.

The value of retesting isn't just seeing a number improve. It's building a feedback loop between intervention and biological response — showing patients, with objective methylation-level data, that what they're doing is working. For most patients, seeing their DunedinPACE slow or their biological age improve is one of the most motivating health data points they've encountered. It makes the invisible visible.

References

1. Fahy, G.M. et al. (2019). Reversal of epigenetic aging and immunosenescent trends in humans. Aging Cell. https://onlinelibrary.wiley.com/doi/10.1111/acel.13028

2. Semaglutide slows epigenetic aging in a randomized trial of HIV-associated lipohypertrophy. Nature Communications (TruDiagnostic co-authored). https://www.nature.com/articles/s41467-026-72861-3

3. One-year Mediterranean diet promotes epigenetic rejuvenation with country- and sex-specific effects: a pilot study from the NU-AGE project. GeroScience. https://link.springer.com/article/10.1007/s11357-019-00149-0

4. The effect of polyphenols on DNA methylation-assessed biological age attenuation: the DIRECT PLUS randomized controlled trial. https://pubmed.ncbi.nlm.nih.gov/37743489/

5. The association between sleep quality and accelerated epigenetic aging with metabolic syndrome in Korean adults. Clinical Epigenetics. https://link.springer.com/article/10.1186/s13148-024-01706-x

6. Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Nature Aging. https://www.nature.com/articles/s43587-024-00793-y

7. Effect of metformin on the epigenetic age of peripheral blood in patients with diabetes mellitus. Frontiers in Genetics. https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.955835/full

8. An epigenetic aging analysis of randomized metformin and weight loss interventions in overweight postmenopausal breast cancer survivors. Clinical Epigenetics. https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-021-01218-y

Exercise, NAD+ precursor, and CoQ10 claims in this draft are directionally consistent with the broader literature but don't yet have a single definitive trial to cite the way the sources above do — flagging for further research before publication if precision matters here.